Leadingpharm CXO-Deep Blue Ocean (Zhengzhou) Approved for Specialized and Special New Small and Medium sized Enterprises of Henan

Recently, the Department of Industry and Information Technology of Henan Province announced the list of the first batch of Specialized and Special New Small and Medium-sized Enterprises to be recognized in 2023. Leadingpharm CXO-Deep Blue Ocean (Zhengzhou) was successfully selected with its professional clinical team, precise and perfect quality management system, and innovative service model. This is also another honor for Deep Blue Ocean after being awarded as High-tech Enterprise, Specialized and Special New Small and Medium sized Enterprise of Zhengzhou, Zhengzhou MAH platform and Liquid Formulation Engineering Research Center.
 

Deep Blue Ocean's inclusion in the list is a recognition by the government of its technological capabilities, innovation capabilities, professionalism, and market position. It is also another fruitful achievement of Deep Blue Ocean's adherence to the strategy of leading technological innovation. In the future, Deep Blue Ocean will continue to be guided by unmet clinical needs, constantly adapt to changes in standard requirements, continuously enhance its own technological level and independent innovation ability, effectively improve market competitiveness and industry influence, promote the high-quality development of the biopharmaceutical industry in Henan Province, and make all-round efforts to build a Healthy China.